A "gift" from China. A living GLP-1?

7 replies8 peopleAug 18, 2026☆ Follow

Summary

What is this new engineered probiotic from China that releases GLP-1, and how realistic is it?

The thread discusses a reported Chinese-engineered probiotic called GIFT that senses high blood sugar and releases GLP-1 automatically. Participants note it has only been tested in animals so far, question the two-year timeline to US shelves, and raise concerns about dosing control and regulatory fit. Some express excitement or dark humor about trying it, while others doubt it will replace existing treatments soon.

What this discussion establishes

GIFT uses modified E. coli that activates GLP-1 production when it detects high sugar
Only animal data mentioned, no human trials yet
Dosing might be hard to control because it depends on bacterial survival and built-in regulation
Could interact with high-fiber diets since colon sugars come from microbial fermentation
Approval path unclear as it does not fit standard drug or probiotic categories

Where people disagree

Whether the two-year timeline is realistic and whether the product will be developed as a tightly regulated drug or something more freely available.

Still open

How well the system will prevent hypoglycemia or work consistently in humans.

Nothing here is advice.

7 replies · 8 people

PatientHarbour28archiveopening postAug 18

An article just appeared describing a Chinese team trying to get a smart diabetes probiotic onto US shelves in about two years. The probiotic is called GIFT and is built to detect high blood sugar then release GLP-1 on its own. The gut already makes GLP-1 normally. Researchers modified an E. coli strain so a gene turns on or off depending on sugar levels, and the gene makes GLP-1 when sugar is high. This opens up a lot of possibilities. I also found a related study on glucose-responsive probiotics tested in mice and monkeys.

Like Same experience Reply

WarmAnchor55archiveAug 18

Looks like my extended stockpile of that med just went up in smoke.

Like Same experience Reply

CopperSignal27archiveAug 18

Two years sounds optimistic when only animal work has been done and no phase 1 trials yet. The plan seems to be treating it as a drug instead of an over-the-counter probiotic, which would be safer if it actually works. It does not fit standard drug rules either, so approval could face extra hurdles even if human tests go well. It is hard to see how the amount of peptide released by the bacteria can be kept under tight control, since that would depend on how many bacteria survive stomach acid plus whatever regulation is built into the strain. You would not want it to cause low blood sugar. I could only find the abstract, not the full paper.

Like Same experience Reply

SteadyCinder62archiveAug 19

Fascinating!!!!

Like Same experience Reply

KeenKettle50archiveAug 20

↳ replying to @CopperSignal27

The only sugars that would reach the colon are monosaccharides produced by microbial fermentation. I wonder if it would work better alongside high fiber intake.

Like Same experience Reply

PatientWillow72archiveAug 20

I nearly mentioned how something similar had already happened back in 2019.

Like Same experience Reply

BlueCinder57archiveAug 20

My first thought was this has to be the plot to our next pandemic.

Like Same experience Reply

SharpWillow20archiveAug 20

I wonder if this could spark a genuine worldwide plague or instead become the latest wonder drug.

Like Same experience Reply

Add your experience

If you have tried it, this topic is still open. Sign in to reply — it takes a minute.